Article info

Download PDFPDF

Original research
Severity of coeliac disease and clinical management study when using a CYP3A4 metabolised medication: a phase I pharmacokinetic study

Authors

  1. Correspondence to Dr David G Bailey; david.bailey{at}lhsc.on.ca
View Full Text

Citation

Chretien ML, Bailey DG, Asher L, et al
Severity of coeliac disease and clinical management study when using a CYP3A4 metabolised medication: a phase I pharmacokinetic study

Publication history

  • Received September 4, 2019
  • Revised January 15, 2020
  • Accepted February 7, 2020
  • First published March 4, 2020.
Online issue publication 
March 04, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.